MedTrace Logo

Periodontal Regeneration of Chronic Periodontal Disease Patients Receiving Stem Cells Injection Therapy

NCT02523651 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-08-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of clinical injection of allogeneic human dental pulp stem cell(DPSC) in local infected periodontal tissue and determine whether injection of allogeneic DPSC is a effective way in the treatment of chronic periodontal disease.

Conditions

  • Periodontal Diseases

Interventions

GENETIC

DPSC injection

A 0.5ml saline preparation containing 1000000 DPSCs were injected at the local periodontal defects immediately after periodontal scaling and root planing.

OTHER

Placebo

A 0.5ml saline preparation were injected at the local periodontal defects immediately after periodontal scaling and root planing.

Sponsors & Collaborators

  • Songlin Wang

    lead OTHER

Principal Investigators

  • Songlin Wang, Ph.D · Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction， Capital Medical University School of Stomatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523651 on ClinicalTrials.gov